XPO heads into the final stretch before July earnings with an unusual tension: short sellers are accumulating at the fastest monthly pace in months, even as the Street keeps marking targets higher.
The most striking dynamic this week is the divergence between bearish positioning and bullish analyst conviction. Short interest has climbed to 6.5% of the free float — up nearly 20% over the past month and 7.6% in the past week alone. That's a meaningful and accelerating build, not noise. At the same time, borrowing costs remain cheap at just 0.51%, and availability is deeply relaxed at 1,335% — meaning there are more than thirteen shares available to borrow for every share already shorted. The lending market is not under any stress. Shorts are building because they want to, not because the squeeze is coming. Options positioning has actually eased from its more defensive posture of recent weeks: the put/call ratio has dropped to 1.54, slightly below its 20-day average of 1.66, which suggests options traders are marginally less cautious now than they were through late May.
The Street, meanwhile, has been pulling targets in one direction all month — up. Wells Fargo lifted its Overweight price objective to $250 last week. Bank of America moved to $246. BMO Capital went to $245. JP Morgan, maintaining Overweight, nudged its target to $210. Most recently, Citigroup — a Neutral holder on the name — raised its target to $236 from $221. The mean target across the covering group is $225, sitting roughly 5% above where the stock closed on June 16 at $214.27. The bull case centres on XPO's transformation into a pure-play LTL carrier, with AI-driven productivity gains and above-market yield growth driving operating ratio improvements toward a high-70s OR by 2027. Bears point to elevated fuel and operating costs, labour constraints, and the sensitivity of LTL volumes to any macro softening — risks that matter when the stock trades at roughly 40x forward earnings and nearly 19x EV/EBITDA. Value ranks in just the 7th percentile against the broader universe on an EV/EBIT basis, a stretched number even for a high-quality compounder.
The institutional base looks supportive rather than fragile. Capital Research holds 13.9% of shares, BlackRock 10.4%, and MFN Partners 9.7% — a concentrated holder list that limits the float meaningfully. Fidelity added nearly 691,000 shares in the latest reported period. The March insider activity was largely award-and-sell clusters around vest dates — including $2.2m in CEO sales — all at prices well below current levels, which adds little signal beyond routine planning. More notable is that no insider has been a net buyer at current prices.
Recent earnings history is thin but worth noting. The May print delivered a clean +5.1% next-day gain, reversing a soft -0.66% reaction from the April release. Peers had a rough week in parallel — ODFL fell 6.9% and ARCB dropped 7.7% while XPO's own 5.8% weekly decline lands it roughly in line with the group. The sector-wide weakness makes it harder to read XPO's short build as idiosyncratic bearishness versus broader freight caution ahead of the Q2 print due July 31.
The next meaningful inflection point is that July 31 earnings date, where the question is less about whether XPO is gaining LTL share and more about whether volume trends held through the quarter — and whether operating ratio progress continued fast enough to justify a valuation that has moved well ahead of a still-recovering freight cycle.
See the live data behind this article on ORTEX.
Open XPO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
